EXHIBIT 10.5 WHEREVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL...Development Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
AGREEMENTConfidentiality Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations • New York
EXHIBIT 10.7 WHEREVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL...Amendment to Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
EXHIBIT 10.3 FINANCIAL COVENANTS ADDENDUM NO. 001 TO MASTER SECURITY AGREEMENT DATED AS OF DECEMBER 22, 2004 THIS ADDENDUM NO. 001 (this "ADDENDUM NO. 001") is made as of the 22 day of December 2004, amends and supplements the above referenced...Master Security Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
RECITALS:Manufacturing and Supply Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
EXHIBIT 10.2 (R011304) *LOAN7000* MASTER SECURITY AGREEMENT dated as of DECEMBER 22, 2004 ("AGREEMENT") THIS AGREEMENT is between GENERAL ELECTRIC CAPITAL CORPORATION (together with its successors and assigns, if any, "SECURED PARTY") and ALKERMES,...Master Security Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
EXHIBIT 10.4 WHEREVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL...Development Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations
RECITALS:Manufacturing Agreement • February 8th, 2005 • Alkermes Inc • Pharmaceutical preparations • New York
